Federal Court of Australia Proceedings No. NSD 273 of 2016

On 20 September 2017, the Federal Court of Australia approved the settlement of the abovementioned Nurofen Class Action in accordance with the Deed of Settlement dated 31 July 2017.

Under the terms of the Settlement Deed, Reckitt Benckiser (Australia) Pty Ltd will pay $3.5 million into a settlement fund for distribution to eligible group members. A settlement scheme to distribute the money will be administered by an independent third party and the closing date to make a claim for compensation is 20 January 2018. Also, the Class Action is dismissed and the Applicants’ legal costs are payable by Reckitt Benckiser (Australia).

The extended date for submission of claims of 3 February 2018 has now closed.

Sapere Group is now responsible for the distribution of funds:

Saphere Research Group
GPO Box 5405

Sydney NSW 2001

A Long-Form Settlement Notice will be sent to all registrants before 1 October 2017, a short form of which is being published in newspapers in every Australian state before 11 October 2017.

This Notice informs group members (those who purchased any Nurofen Specific Pain Range products in Australia between 1 January 2011 and 31 December 2015) of the settlement and its approval, their right to claim compensation from the settlement fund and how to make a claim before the closing date of 20 January 2018.